Skip to main content
. Author manuscript; available in PMC: 2012 Jan 17.
Published in final edited form as: Hum Reprod. 2011 Apr 12;26(7):1675–1684. doi: 10.1093/humrep/der114

TABLE II.

Clinical characteristics of control, type 1 diabetic (including pre-eclamptic) and type 2 diabetic patients across pregnancy, and of pre-eclamptic patients in the third trimester.

Control (n=10) Type 1 Diabetic (n=9) Type 2 Diabetic (n=3) Pre-Eclamptic (n=2)
Blood Pressure (mmHg) 115/73 (± 1.9/1.3) 122/73 (± 2.7/2.0) 133/87 (± 14.5/3.3) 142/87 (± 10.5/8.5)
Blood Glucose (mmol/L) NAD 8.7 (± 1.2) 10.1 (± 0.0) NM
HbA1C (% of Hb) NAD 7.9 (± 0.6) NM NM
Urine protein/24 hour (mg/dL) 4.0 (± 3.0) 63.3 (± 27.2) 0.0 (± 0.0) 15.0 (± 15.0)

Data are mean ± SEM. Both PE patients are type 1 diabetic. Hb, hemoglobin. NAD, no abnormality detected. NM, not measured. Normal ranges for blood glucose (3.3–5.6 mmol/L) and HbA1C (3.6–5.0% of Hb). Trace values for urine protein/24 hour are 5–20 mg/dL.